Johnson & Johnson to Settle 845 Levaquin Lawsuits
Johnson & Johnson (J&J) is close to settling claims involving a significant portion of the Levaquin multidistrict litigation (MDL). Bloomberg reports the proposed agreement involves 845 plaintiffs who alleged that J&J and its Ortho-McNeil Pharmaceutical unit failed to warn about the risk of serious tendon damage from the antibiotic Levaquin